{"id":"https://openalex.org/W4403434010","doi":"https://doi.org/10.21203/rs.3.rs-4786010/v1","title":"Therapeutic efficacy of galectin-1 inhibitor in treating malignant peripheral nerve sheath tumor","display_name":"Therapeutic efficacy of galectin-1 inhibitor in treating malignant peripheral nerve sheath tumor","publication_year":2024,"publication_date":"2024-10-15","ids":{"openalex":"https://openalex.org/W4403434010","doi":"https://doi.org/10.21203/rs.3.rs-4786010/v1"},"language":"en","primary_location":{"id":"doi:10.21203/rs.3.rs-4786010/v1","doi":"https://doi.org/10.21203/rs.3.rs-4786010/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-4786010/v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"volume":null,"type":"preprint","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.21203/rs.3.rs-4786010/v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016289021","display_name":"Tsung\u2010Chieh Shih","orcid":"https://orcid.org/0000-0001-7992-1504","observed_orcids":["https://orcid.org/0000-0001-7992-1504"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tsung-Chieh Shih","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center"],"raw_orcid":"https://orcid.org/0000-0001-7992-1504","affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048240231","display_name":"Hsiao\u2010Chi Wang","orcid":"https://orcid.org/0009-0009-8343-9353","observed_orcids":["https://orcid.org/0009-0009-8343-9353"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hsiao-Chi Wang","raw_affiliation_strings":["Kibio Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kibio Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066152699","display_name":"Keila E. Torres","orcid":"https://orcid.org/0000-0002-1855-0989","observed_orcids":["https://orcid.org/0000-0002-1855-0989"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keila Torres","raw_affiliation_strings":["MD Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002544136","display_name":"Roger Xia","orcid":"https://orcid.org/0009-0005-4106-7425","observed_orcids":["https://orcid.org/0009-0005-4106-7425"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roger Xia","raw_affiliation_strings":["Stanford University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060037035","display_name":"Marcio H. Malogolowkin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcio Malogolowkin","raw_affiliation_strings":["University of California, Davis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Davis","institution_ids":["https://openalex.org/I84218800"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087110349","display_name":"Ssu\u2010Wei Hsu","orcid":"https://orcid.org/0000-0002-6829-2412","observed_orcids":["https://orcid.org/0000-0002-6829-2412"]},"institutions":[{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ssu-Wei Hsu","raw_affiliation_strings":["University of California Davis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California Davis","institution_ids":["https://openalex.org/I84218800"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049792656","display_name":"Ching\u2010Hsien Chen","orcid":"https://orcid.org/0000-0002-4211-9988","observed_orcids":["https://orcid.org/0000-0002-4211-9988","https://orcid.org/0000-0002-3178-6697"]},"institutions":[{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ching-Hsien Chen","raw_affiliation_strings":["University of California Davis"],"raw_orcid":"https://orcid.org/0000-0002-4211-9988","affiliations":[{"raw_affiliation_string":"University of California Davis","institution_ids":["https://openalex.org/I84218800"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12387","display_name":"Galectins and Cancer Biology","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12387","display_name":"Galectins and Cancer Biology","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11173","display_name":"Neurofibromatosis and Schwannoma Cases","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/galectin-1","display_name":"galectin-1","score":0.9049999713897705},{"id":"https://openalex.org/keywords/malignant-peripheral-nerve-sheath-tumor","display_name":"malignant peripheral nerve sheath tumor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/h-ras-g12v","display_name":"HRAS G12V","score":0.9259999990463257},{"id":"https://openalex.org/keywords/ras-erk-pathway","display_name":"Ras/ERK pathway","score":0.8029999732971191},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6919999718666077},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.9259999990463257},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.8980000019073486},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8299999833106995},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.9900000095367432},{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.7720000147819519}],"concepts":[{"id":"https://openalex.org/C3018498973","wikidata":"https://www.wikidata.org/wiki/Q9620","display_name":"Peripheral nerve","level":2,"score":0.5577895641326904},{"id":"https://openalex.org/C46762472","wikidata":"https://www.wikidata.org/wiki/Q178648","display_name":"Peripheral","level":2,"score":0.5563115477561951},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5356276631355286},{"id":"https://openalex.org/C2778173781","wikidata":"https://www.wikidata.org/wiki/Q654485","display_name":"Malignant peripheral nerve sheath tumor","level":3,"score":0.5074440836906433},{"id":"https://openalex.org/C2776336362","wikidata":"https://www.wikidata.org/wiki/Q18028529","display_name":"Galectin-3","level":2,"score":0.43928149342536926},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43280935287475586},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.39870524406433105},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.251240074634552},{"id":"https://openalex.org/C105702510","wikidata":"https://www.wikidata.org/wiki/Q514","display_name":"Anatomy","level":1,"score":0.13288837671279907},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.0871129035949707}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.21203/rs.3.rs-4786010/v1","doi":"https://doi.org/10.21203/rs.3.rs-4786010/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-4786010/v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.21203/rs.3.rs-4786010/v1","doi":"https://doi.org/10.21203/rs.3.rs-4786010/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-4786010/v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409002726","https://openalex.org/W4403450224","https://openalex.org/W2946714830","https://openalex.org/W4281928166","https://openalex.org/W4309747420","https://openalex.org/W2128434997","https://openalex.org/W2740732030","https://openalex.org/W2100516555","https://openalex.org/W2017635793","https://openalex.org/W150554235"],"abstract_inverted_index":{"Abstract":[0],"Malignant":[1],"peripheral":[2],"nerve":[3],"sheath":[4],"tumors":[5],"(MPNSTs)":[6],"are":[7],"aggressive":[8],"sarcomas":[9],"with":[10,56,120],"limited":[11],"treatment":[12],"options.":[13],"Galectin-1":[14],"(Gal-1)":[15],"is":[16,22],"crucial":[17,23],"in":[18,24,76,88],"Ras":[19,40,67],"activation,":[20],"which":[21],"MPNST":[25,77,90,125],"pathology.":[26],"We":[27],"aimed":[28],"to":[29,51],"disrupt":[30],"the":[31,39,73],"Gal-1/Ras":[32],"interaction":[33],"as":[34,113],"a":[35,48,114],"therapeutic":[36,122],"strategy.":[37],"Targeting":[38],"binding":[41],"pocket":[42],"on":[43,98],"Gal-1,":[44],"we":[45,59],"designed":[46,117],"LLS30,":[47],"Gal-1":[49,118,132],"inhibitor":[50,119],"bind":[52],"where":[53],"H-Ras(G12V)":[54],"interacts":[55],"Gal-1.":[57],"Here,":[58],"show":[60],"that":[61],"LLS30":[62,81,112],"disrupts":[63],"Gal-1\u2013Ras":[64],"interactions,":[65],"causing":[66],"delocalization":[68],"and":[69,86,107,126,133],"subsequent":[70],"suppression":[71],"of":[72],"Ras/ERK":[74],"pathway":[75],"cells.":[78],"In":[79],"vivo,":[80],"significantly":[82],"inhibited":[83],"tumor":[84],"growth":[85],"metastasis":[87],"human":[89],"xenograft":[91],"models.":[92],"RNA-seq":[93],"analysis":[94],"revealed":[95],"LLS30\u2019s":[96],"impact":[97],"key":[99],"cellular":[100],"pathways,":[101],"including":[102],"p53,":[103],"interferon":[104],"gamma,":[105],"EMT,":[106],"proliferation.":[108],"These":[109],"findings":[110],"highlight":[111],"potent,":[115],"rationally":[116],"promising":[121],"implications":[123],"for":[124],"potentially":[127],"other":[128],"malignancies":[129],"driven":[130],"by":[131],"Ras.":[134]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-10-16T00:00:00"}